BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23217540)

  • 1. Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse.
    Kong CS; Cao H; Kwok S; Nguyen CM; Jordan RC; Beaudry VG; Attardi LD; Le QT
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jan; 115(1):95-103. PubMed ID: 23217540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis.
    Beaudry VG; Jiang D; Dusek RL; Park EJ; Knezevich S; Ridd K; Vogel H; Bastian BC; Attardi LD
    PLoS Genet; 2010 Oct; 6(10):e1001168. PubMed ID: 20975948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PERP-ing into diverse mechanisms of cancer pathogenesis: Regulation and role of the p53/p63 effector PERP.
    Roberts O; Paraoan L
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188393. PubMed ID: 32679166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of loss of the p53/p63 target gene PERP at the surgical margin as a potential predictor of local relapse in head and neck squamous cell carcinoma.
    Holmes BJ; von Eyben R; Attardi LD; Kong CS; Le QT; Nathan CO
    Head Neck; 2020 Nov; 42(11):3188-3196. PubMed ID: 33034918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias.
    Bortoluzzi MC; Yurgel LS; Dekker NP; Jordan RC; Regezi JA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):698-704. PubMed ID: 15583543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new Perp in the lineup: linking p63 and desmosomal adhesion.
    Ihrie RA; Attardi LD
    Cell Cycle; 2005 Jul; 4(7):873-6. PubMed ID: 15970683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer.
    Dusek RL; Bascom JL; Vogel H; Baron S; Borowsky AD; Bissell MJ; Attardi LD
    Breast Cancer Res; 2012 Apr; 14(2):R65. PubMed ID: 22515648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of p63 is correlated to poor prognosis in squamous cell carcinoma of the tongue.
    Loljung L; Coates PJ; Nekulova M; Laurell G; Wahlgren M; Wilms T; Widlöf M; Hansel A; Nylander K
    J Oral Pathol Med; 2014 Jan; 43(1):14-9. PubMed ID: 23607508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.
    Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC
    Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
    de Oliveira LR; Ribeiro-Silva A; Zucoloto S
    J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 aberrations in oral sub mucous fibrosis and oral cancer detected by immunohistochemistry.
    Bathi RJ; Prabhat
    Indian J Dent Res; 2003; 14(4):214-9. PubMed ID: 15328987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential PERP regulation by TP63 mutants provides insight into AEC pathogenesis.
    Beaudry VG; Pathak N; Koster MI; Attardi LD
    Am J Med Genet A; 2009 Sep; 149A(9):1952-7. PubMed ID: 19353588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma.
    Higashikawa K; Yoneda S; Tobiume K; Saitoh M; Taki M; Mitani Y; Shigeishi H; Ono S; Kamata N
    Int J Cancer; 2009 Jun; 124(12):2837-44. PubMed ID: 19267405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein.
    Hall PA; Woodman AC; Campbell SJ; Shepherd NA
    Gut; 2001 Nov; 49(5):618-23. PubMed ID: 11600462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoexpression of p53 and hMSH2 in oral squamous cell carcinoma and oral dysplastic lesions in Yemen: relationship to oral risk habits and prognostic factors.
    Helal Tel A; Fadel MT; El-Thobbani AK; El-Sarhi AM
    Oral Oncol; 2012 Feb; 48(2):120-4. PubMed ID: 21937259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.